Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Frontage Holdings Corp (Frontage), a subsidiary of Hong Kong Tigermed Co Ltd, is a contract research organization (CRO). The company's main activities include drug discovery, drug development, pharmaceutical product development, and laboratory testing services. It services include API synthesis, drug metabolism and pharmacokinetics, safety and toxicology, formulation development, GMP manufacturing, analytical services, clinical trials, bioanalytical services and central lab operations. Frontage services are utilized by customers in the pharmaceutical, biotechnology, agrochemical and chemical industries. The company operates in Canada, Hong Kong, the US, and China. Frontage is headquartered in Exton, Pennsylvania, the US.
Headquarters
United States of America
Address
700 Pennsylvania Drive, Exton, 19341
Website
www.frontagelab.com
Telephone
1 610 2320100
No of Employees
1,523
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
1521 (HKG)
Revenue (2024)
$256.7M
0.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
758.8%
(2024 vs 2023)
Market Cap*
$247.3M
Net Profit Margin (2024)
XYZ
754.8%
(2024 vs 2023)
* As of and is in US$
Frontage Holdings Corp premium industry data and analytics
Products and Services
| Services |
|---|
| Drug Discovery |
| Custom Synthesis |
| Medicinal Chemistry Services |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Frontage Holdings Corp | HitGen Inc | Advanced Clinical LLC | Labcorp Drug Development Inc | Olon Ricerca Biosciences LLC |
|---|---|---|---|---|---|
| Headquarters | United States of America | China | United States of America | United States of America | United States of America |
| City | Exton | Chengdu | Deerfield | Burlington | Concord |
| State/Province | Pennsylvania | Sichuan | Illinois | North Carolina | Ohio |
| No. of Employees | 1,523 | 483 | - | - | - |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Song Li | Chairman | Executive Board | 2021 | 68 |
| Zhongping Lin | Director; Co-Chief Executive Officer | Executive Board | 2025 | 62 |
| Wentao Zhang | Co-Chief Executive Officer; Director | Executive Board | 2025 | 57 |
| Sean Yu | Senior Vice President; Head - Global Drug Discovery Services and and Drug Metabolism and Pharmacokinetics Services | Senior Management | 2025 | - |
| Yaodong Huang | Senior Vice President - Frontage Chemistry Services | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer